Navigation Links
AAP Initiates Public Relations Effort to Counter Bad Vaccine Publicity
Date:2/15/2008

National Autism Association Requests AAP Instead Focus on Removing Unnecessary Toxins From Vaccines and Providing Medical Treatments for Children with Autism

CHICAGO, Feb. 15 /PRNewswire-USNewswire/ -- The American Academy of Pediatrics (AAP) has initiated a "parent spokesperson" campaign to counter recent negative publicity surrounding toxins in vaccines, requesting parent vaccine proponents to conduct media interviews as "part of our ongoing response to media stories regarding autism and vaccines."

The negative publicity stems from long-standing reports from thousands of parents that the mercury-based vaccine preservative thimerosal contributed to their children's regressive autism. In 1999, the AAP issued a statement requesting the toxin be phased out of vaccines, but has since continued supporting its use as a preservative, even fighting against legislation in several states which would ban the poison from children's vaccines.

Although the mercury content in many vaccines on the current schedule has been reduced to trace amounts, these trace amounts are not regulated by the FDA. Large doses of mercury still remain in some vaccines, including flu shots. Other highly toxic substances including aluminum remain as well.

Parent advocates for children's health believe the AAP should direct their resources towards increasing the safety of vaccines, rather than damage-control media campaigns and attempts to censor fictional TV shows such as ABC's "Eli Stone." "Their resources are so valuable," says Rita Shreffler, parent and Executive Director of NAA. "It is my hope that the AAP will stop defending the continued use of poison in vaccines and instead direct that energy towards implementing promising medical treatments that have thus far been denied to the vast number of children diagnosed with autism. In the last several years, we have come to know that improvement and even recovery from autism is possible when children receive appropriate medical attention, yet the AAP continues to dismiss these treatments."

A growing body of scientific research including a Centers for Disease Control study from 2000 indicates a link between thimerosal exposure and several specific neurological injuries including autism. For years, Shreffler and her colleagues have requested the toxins be removed from all vaccines.

"If the AAP truly wants the best possible publicity for vaccines, they can start by discouraging the use of toxic components."

For more information, visit http://www.nationalautism.org.

CONTACT: Wendy Fournier, Portsmouth, RI, 401-835-5828

Rita Shreffler, Nixa, MO, 401-632-6452


'/>"/>
SOURCE National Autism Association
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Tyco International Increases Quarterly Dividend 36 Percent to 15 Cents per Share; Initiates New $1 Billion Share Repurchase Program
2. Chemical Diversity Initiates International Prostrate Cancer Discovery Partnership
3. Vista Partners Initiates Coverage on Raptor Pharmaceuticals Corp.
4. GenPrime Initiates External Clinical Trials of its Bacterial Contamination Test for Rapid Detection of Bacteria in Platelets
5. U.S. Oncology Initiates Complete Phase Ib Trial of Brostallicin Combination Therapy in Advanced Solid Tumors
6. Harbinger Research Initiates Coverage on HearAtLast
7. Wyeth Consumer Healthcare Initiates Voluntary Recall and Replacement Program for Several Robitussin Products and Childrens Dimetapp Cold & Chest Congestion
8. MAP Pharmaceuticals Initiates Phase 2a Clinical Trial of Combination Therapy in Adult Patients with Asthma
9. Amira Pharmaceuticals Announces Favorable Phase 1 Clinical Trial Results for Lead Product Candidate AM103 and Initiates Clinical Studies for the 2nd Entry Molecule for the Treatment of Respiratory and Cardiovascular Disease
10. Arete Therapeutics Initiates Phase 1 Clinical Trial For AR9281 as a First-in-Class Antihypertensive Agent
11. Isolagen Initiates Phase III Clinical Program to Investigate Isolagen Therapy(TM) for the Treatment of Acne Scars
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... ... April 24, 2017 , ... Veteran Theresa James awoke to the sound ... forever. , In “Healing Tears,” James depicts every parent’s worst nightmare, when her three ... began journaling conversations and situations throughout my divorce,” James said. “After the death of ...
(Date:4/24/2017)... ... 24, 2017 , ... The world-class designers of Happy Gadget ... novel lifesaving device for the everyday use of parents worldwide. It is a ... read a child’s vital signs, and detect unusual symptoms or physical patterns. This ...
(Date:4/24/2017)... ... 24, 2017 , ... symplrTM, a leading provider of software ... Kyle Allain has joined the company as Vice President and General Manager of ... payor and managed care solutions. , A seasoned executive with more than ...
(Date:4/24/2017)... ... April 24, 2017 , ... MAP ... elevated anxiety levels in people with addiction who are served by MAP’s patient ... biosensing wearable device that monitors heart and breath rates to identify anxiety levels ...
(Date:4/24/2017)... ... April 24, 2017 , ... As a former supermodel known for ... The good news for single women is that she put all the words in ... April 25th. Joan's insight, personal experiences and sparkling sense of humor have inspired her ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)...  RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage ... unmet medical needs, today announced that it will ... development program, based on its proprietary self-delivering RNAi ... (SID) 76 th Annual Meeting.  The SID ... relevant to skin health and disease through education, ...
(Date:4/20/2017)... , April 20, 2017 Research ... Pharmacogenomics Market Size, Market Share, Application Analysis, Regional Outlook, Growth ... report to their offering. ... The global pharmacogenomics market was valued at US$ 7,167.6 ... Mn by 2024, expanding at a CAGR of 5.6% from ...
(Date:4/19/2017)... Cardiology devices segment is anticipated to reach the highest market ... segment is likely to create absolute $ opportunity of a ... By the end of 2027, Cardiology Devices segment is projected ... expanding at a CAGR of 18.4% over the forecast period. ... reprocessed medical devices market in terms of revenue ...
Breaking Medicine Technology: